Mitochondria Are Potential Targets for the Development of New Drugs Against Neutrophilic Inflammation in Severe Pneumonia Including COVID-19

Front Pharmacol. 2021 Jan 29:12:609508. doi: 10.3389/fphar.2021.609508. eCollection 2021.
No abstract available

Keywords: COVID-19; NADPH oxidase; NETosis; mitochondria; neutrophil extracellular traps; neutrophils; pneumonia; reactive oxygen species.